FDA awards 15 grants for clinical trials to stimulate product development for rare diseases Read more
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets Read more
Kura Oncology Announces Positive Phase 2 Study for Tipifarnib in HRAS Mutant Head and Neck Cancer Read more